NuvaRing Lawsuit Plaintiff Experienced Symptoms within Two Months

New York, NYIt didn't take long for plaintiff Stephanie Heap to regret her decision to adopt the use of NuvaRing Birth Control as her contraceptive of choice. From the time the New York woman began using the birth control device to her first experience with shortness of breath, two months had elapsed.

Heap has filed a NuvaRing lawsuit against the manufacturers of NuvaRing, Organon USA.

Industry watcher and avid blogger Tom Lamb noted in Drug Injury Watch (3/15/12) that there were no fewer than 950 NuvaRing lawsuits percolating in the system as of December 31of last year.

"Of these cases, approximately 820 are, or will be pending in the NuvaRing MDL in the US District Court for the Eastern District of Missouri before Judge Rodney Sippel, and approximately 125 are pending in coordinated discovery proceedings in the Bergen County Superior Court of New Jersey before Judge Brian R. Martinotti," Lamb writes.

"Four additional cases are pending in various other state courts."

NuvaRing Contraceptive Ring is a birth control device placed near the cervix and releases a dose of synthetic hormones??"etongestrel (a progestin) and ethinyl estradiol (estrogen)??"over a 21-day period. The US Food and Drug Administration (FDA) approved it for use in 2001.

In her NuvaRing dangers lawsuit, Heap asserts that she began using the contraceptive device in February 2009. By April she was experiencing shortness of breath, and was later diagnosed with bilateral pulmonary emboli, according to Health Law Week (3/30/12)

Heap's NuvaRing lawsuit alleges that NuvaRing manufacturer Organon failed to inform consumers as to the risk for NuvaRing blood clot and venous thromboembolism, including deep vein thrombosis and pulmonary embolism.

She is seeking unspecified damages in a complaint filed March 16 of this year.

Lamb notes in his blog that NuvaRing lawsuits generally surround injuries involving NuvaRing blood clots, pulmonary embolism, deep vein thrombosis, NuvaRing stroke and NuvaRing heart attack. Health Law Week reports that Organon was acquired by Schering Corp. in 2007.